Sex Difference in the Association Between Serum Versican and Albuminuria in Patients with Type 2 Diabetes Mellitus

References

• Artasensi A, Pedretti A, Vistoli G., et al. Type 2 diabetes mellitus: a review of multi-target drugs. Molecules. 2020;25(8):1987. doi:10.3390/molecules25081987
   PubMed Web of Science ®Google Scholar
• Martínez-Castelao A, Navarro-González JF, Górriz JL, et al. The concept and the epidemiology of diabetic nephropathy have changed in recent years. J Clin Med. 2015;4(6):1207–1216. doi:10.3390/jcm4061207
   PubMed Web of Science ®Google Scholar
• Fu H, Liu S, Bastacky SI, et al. Diabetic kidney diseases revisited: a new perspective for a new era. Mol Metab. 2019;30:250–263. doi:10.1016/j.molmet.2019.10.005
   PubMed Web of Science ®Google Scholar
• Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol. 2002;14(5):617–623. doi:10.1016/S0955-0674(02)00375-7
   PubMed Web of Science ®Google Scholar
• Xu Q, Li B, Wang Y, et al. Identification of VCAN as hub gene for diabetic kidney disease immune injury using integrated bioinformatics analysis. Front Physiol. 2021;12:651690. doi:10.3389/fphys.2021.651690
   PubMed Web of Science ®Google Scholar
• Han R, Hu S, Qin W, et al. C3a and suPAR drive versican V1 expression in tubular cells of focal segmental glomerulosclerosis. JCI Insight. 2019;4(7):e122912. doi:10.1172/jci.insight.122912
   PubMed Web of Science ®Google Scholar
• Li S, Zhan JK, Wang YJ, et al. Exosomes from hyperglycemia-stimulated vascular endothelial cells contain versican that regulate calcification/senescence in vascular smooth muscle cells. Cell Biosci. 2019;9(1):1. doi:10.1186/s13578-018-0263-x
   PubMedGoogle Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical Care in diabetes—2022 abridged for primary care providers. Clin Diabetes. 2022;40(1):10–38. doi:10.2337/cd22-as01
   PubMedGoogle Scholar
• The Japanese Society of Nephrology. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease. Jpn J Nephrol. 2012;54:1031–1189.
   Google Scholar
• Christofides EA, Desai N. Optimal early diagnosis and monitoring of diabetic kidney disease in type 2 diabetes mellitus: addressing the barriers to albuminuria testing. J Prim Care Commun Health. 2021;12:21501327211003683. doi:10.1177/21501327211003683
   Web of Science ®Google Scholar
• Jackson CE, Solomon SD, Gerstein HC, et al. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet. 2009;374(9689):543–550. doi:10.1016/S0140-6736(09)61378-7
   PubMed Web of Science ®Google Scholar
• Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015;3(7):514–525. doi:10.1016/S2213-8587(15)00040-6
   PubMed Web of Science ®Google Scholar
• Al-Trad B, Al-Batayneh K, El-Metwally S, et al. Nigella sativa oil and thymoquinone ameliorate albuminuria and renal extracellular matrix accumulation in the experimental diabetic rats. Eur Rev Med Pharmacol Sci. 2016;20(12):2680–2688.
   PubMed Web of Science ®Google Scholar
• Rudnicki M, Perco P, Neuwirt H, et al. Increased renal versican expression is associated with progression of chronic kidney disease. PLoS One. 2012;7(9):e44891. doi:10.1371/journal.pone.0044891
   PubMed Web of Science ®Google Scholar
• Wight TN, Kang I, Evanko SP, et al. Versican-A critical extracellular matrix regulator of immunity and inflammation. Front Immunol. 2020;11:512. doi:10.3389/fimmu.2020.00512
   PubMed Web of Science ®Google Scholar
• Han CY, Kang I, Harten IA, et al. Adipocyte-derived versican and macrophage-derived biglycan control adipose tissue inflammation in obesity. Cell Rep. 2020;31(13):107818. doi:10.1016/j.celrep.2020.107818
   PubMed Web of Science ®Google Scholar
• Wight TN, Kang I, Merrilees MJ. Versican and the control of inflammation. Matrix Biol. 2014;35:152–161. doi:10.1016/j.matbio.2014.01.015
   PubMed Web of Science ®Google Scholar
• Liu L, Bai F, Song H, et al. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy. Redox Biol. 2022;50:102260. doi:10.1016/j.redox.2022.102260
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhao H, Han Y, et al. HIF-1α ameliorates tubular injury in diabetic nephropathy via HO-1-mediated control of mitochondrial dynamics. Cell Prolif. 2020;53(11):e12909. doi:10.1111/cpr.12909
   PubMed Web of Science ®Google Scholar
• Hung PH, Hsu YC, Chen TH, et al. Recent advances in diabetic kidney diseases: from kidney injury to kidney fibrosis. Int J Mol Sci. 2021;22(21):11857. doi:10.3390/ijms222111857
   PubMed Web of Science ®Google Scholar
• Li S, Li N, Li L, et al. Association of serum bilirubin levels with macro- and microvascular complications in Chinese people with type 2 diabetes mellitus: new insight on gender differences. Diabetes Metab Syndr Obes. 2023;16:597–606. doi:10.2147/DMSO.S403483
   PubMed Web of Science ®Google Scholar
• Mu PW, Jiang P, Wang MM, et al. Oestrogen exerts anti-inflammation via p38 MAPK/NF-κB cascade in adipocytes. Obes Res Clin Pract. 2016;10(6):633–641. doi:10.1016/j.orcp.2016.02.007
   PubMed Web of Science ®Google Scholar
• Dellê H, Rocha JR, Cavaglieri RC, et al. Antifibrotic effect of tamoxifen in a model of progressive renal disease. J Am Soc Nephrol. 2012;23(1):37–48. doi:10.1681/ASN.2011010046
   PubMed Web of Science ®Google Scholar
• Nahavandi S, Ahmadi S, Sobhani SA, et al. A high dose of estrogen can improve renal ischemia-reperfusion-induced pulmonary injury in ovariectomized female rats. Can J Physiol Pharmacol. 2021;99(12):1241–1252. doi:10.1139/cjpp-2021-0130
   PubMed Web of Science ®Google Scholar
• Holmes S, Singh M, Su C, et al. Effects of oxidative stress and testosterone on pro-inflammatory signaling in a female rat dopaminergic neuronal cell line. Endocrinology. 2016;157(7):2824–2835. doi:10.1210/en.2015-1738
   PubMed Web of Science ®Google Scholar
• Retnakaran R, Cull CA, Thorne KI, et al. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective diabetes study 74. Diabetes. 2006;55(6):1832–1839. doi:10.2337/db05-1620
   PubMed Web of Science ®Google Scholar
• Salgado RM, Covarrubias AC, Favaro RR, et al. Estradiol induces transcriptional and posttranscriptional modifications in versican expression in the mouse uterus. J Mol Histol. 2013;44(2):221–229. doi:10.1007/s10735-012-9476-1
   PubMed Web of Science ®Google Scholar
• Theofilatos K, Stojkovic S, Hasman M, et al. Proteomic atlas of atherosclerosis: the contribution of proteoglycans to sex differences, plaque phenotypes, and outcomes. Circ Res. 2023;133(7):542–558. doi:10.1161/CIRCRESAHA.123.322590
   PubMed Web of Science ®Google Scholar
• Coresh J, Heerspink HJL, Sang Y, et al. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 2019;7(2):115–127. doi:10.1016/S2213-8587(18)30313-9
   PubMed Web of Science ®Google Scholar
• Persson F, Bain SC, Mosenzon O, et al. Changes in albuminuria predict cardiovascular and renal outcomes in type 2 diabetes: a post hoc analysis of the LEADER Trial. Diabetes Care. 2021;44(4):1020–1026. doi:10.2337/dc20-1622
   PubMed Web of Science ®Google Scholar
• Buyadaa O, Magliano DJ, Salim A, et al. Risk of rapid kidney function decline, all-cause mortality, and major cardiovascular events in nonalbuminuric chronic kidney disease in type 2 diabetes. Diabetes Care. 2020;43(1):122–129. doi:10.2337/dc19-1438
   PubMed Web of Science ®Google Scholar
• Looker HC, Mauer M, Saulnier PJ, et al. Changes in albuminuria but not GFR are associated with early changes in kidney structure in type 2 diabetes. J Am Soc Nephrol. 2019;30(6):1049–1059. doi:10.1681/ASN.2018111166
   PubMed Web of Science ®Google Scholar
• Guo H, Li Y, Qiu L, et al. Gua Lou Er Chen decoction attenuates atherosclerosis by reducing proteoglycans accumulation and inflammation. Phytomedicine. 2023;115:154811. doi:10.1016/j.phymed.2023.154811
   PubMed Web of Science ®Google Scholar